Individualized Medicine Enabled by Genomics in Saudi Arabia
Overview
Authors
Affiliations
The biomedical research sector in Saudi Arabia has recently received special attention from the government, which is currently supporting research aimed at improving the understanding and treatment of common diseases afflicting Saudi Arabian society. To build capacity for research and training, a number of centres of excellence were established in different areas of the country. Among these, is the Centre of Excellence in Genomic Medicine Research (CEGMR) at King Abdulaziz University, Jeddah, with its internationally ranked and highly productive team performing translational research in the area of individualized medicine. Here, we present a panorama of the recent trends in different areas of biomedical research in Saudi Arabia drawing from our vision of where genomics will have maximal impact in the Kingdom of Saudi Arabia. We describe advances in a number of research areas including; congenital malformations, infertility, consanguinity and pre-implantation genetic diagnosis, cancer and genomic classifications in Saudi Arabia, epigenetic explanations of idiopathic disease, and pharmacogenomics and personalized medicine. We conclude that CEGMR will continue to play a pivotal role in advances in the field of genomics and research in this area is facing a number of challenges including generating high quality control data from Saudi population and policies for using these data need to comply with the international set up.
The future of personalized medicine in Saudi Arabia: Opportunities and challenges.
Mawkili W Saudi Med J. 2025; 46(1):19-25.
PMID: 39779366 PMC: 11717103. DOI: 10.15537/smj.2025.46.1.20240700.
Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma.
Hanbazazh M, Samman A, Samargandy S, Al-Maghrabi J Libyan J Med. 2023; 18(1):2283953.
PMID: 37988377 PMC: 11018318. DOI: 10.1080/19932820.2023.2283953.
Alosaimi A, Zamzam S, Berdida D, Villagracia H J Taibah Univ Med Sci. 2022; 17(5):755-764.
PMID: 36050964 PMC: 9396048. DOI: 10.1016/j.jtumed.2022.03.001.
Alrefaei A, Hawsawi Y, Almaleki D, Alafif T, Alzahrani F, Bakhrebah M Sci Rep. 2022; 12(1):1405.
PMID: 35082362 PMC: 8791994. DOI: 10.1038/s41598-022-05296-7.
Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.
Albitar L, Alchamat G BMC Health Serv Res. 2021; 21(1):1031.
PMID: 34592972 PMC: 8485485. DOI: 10.1186/s12913-021-07040-9.